<DOC>
	<DOCNO>NCT01120769</DOCNO>
	<brief_summary>The purpose study test hypothesis acetaminophen reduce lipid peroxidation isoprostane formation reperfusion percutaneous revascularization acute myocardial infarction .</brief_summary>
	<brief_title>Acetaminophen Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Patients present STEMI Duration symptom &gt; 12 hour Suspected LM proximal LAD occlusion ( base EKG interpretation ) Hemodynamic instability Acetaminophen use prior 24 hour Use dipyridamole , Aggrenox , formulation aspirin extendedrelease dipyridamole , within 48 hour Current use follow medication : phenytoin , valproic acid , phenobarbital , topiramate , rifampin , carbamazepine , cyclophosphamide , ritonavir , efavirenz , St. John 's Wort Chronic heavy alcohol use Chronic liver disease ( nonalcoholic fatty liver infiltration ) Severe valvular heart disease Stroke past 60 day Active major bleed Major surgery past 30 day Ongoing treatment active malignancy Life expectancy le 12 month determine patient 's attend physician Pregnancy asthma severe COPD active wheeze presentation allergy prior adverse reaction adenosine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Lipid Peroxidation</keyword>
</DOC>